MedTrace Logo

Motor Skill Proficiency After Equine-assisted Activities and Brain-building Tasks

NCT04158960 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2019-11-12

No results posted yet for this study

Summary

There is no current research to support the efficacy of a combination of equine-assisted activities (EAA) and brain building activities to influence motor skill competencies in youth with neurodevelopmental disorders (ND). The primary objective of this study was to quantify changes in motor skill proficiency before and after 8 weeks of EAA and brain-building activities in youth with ND. A secondary objective was to quantify changes in motor skill proficiency before and after 1 year of EAA and brain-building activities in youth with ND.

Conditions

  • Motor Delay
  • Motor Skills Disorders
  • Autism Spectrum Disorder
  • Attention Deficit Hyper Activity
  • Intellectual Disability
  • Sensory Disorders

Interventions

BEHAVIORAL

Equine-assisted activities

Participants performed riding-related activities on and off of a horse once per week for 8 weeks

BEHAVIORAL

GaitWay program

Participants performed riding-related activities on and off of a horse, along with brain-building activities including balance tasks, swinging, spinning, music therapy, and sensory tasks, all once per week for 8 weeks

Sponsors & Collaborators

  • Texas Woman's University

    lead OTHER

Principal Investigators

  • Brandon R Rigby, PhD · Texas Woman's University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-01
Primary Completion
2018-05-31
Completion
2018-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04158960 on ClinicalTrials.gov